Delivery Order SPE2DR25D1022-SPE2DR26FQU7A
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $26,231.49 for Voranigo 40 mg tablets (30-count packages) by the Defense Logistics Agency (DLA). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, and was competitively awarded without set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,722.86 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was established on January 13, 2026, with an ultimate completion date of February 4, 2026. The contractor will perform from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $76,246.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Voranigo 10 mg tablets (30-count packages). The contract, which is non-set-aside and competitively awarded, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 14, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) with a completion date of February 3, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $56.7K to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on January 6, 2026, with completion expected by January 28, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare needs,...
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) with a firm fixed-price structure. The contract is classified as a non-set-aside award, indicating it was competitively procured. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent...
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on December 18, 2025, for Voranigo 40 mg tablets (30-count packages) with a ceiling value of $57,107.82. This firm fixed price, non-set-aside delivery order is scheduled for completion by January 12, 2026, and represents a direct pharmaceutical supply to support federal medical procurement needs. The award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for supply of Voranigo 40 mg tablets (30-count packages) with a ceiling value of $27,094.95. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $26,231.49 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 12, 2025, with an ultimate completion date of December 4, 2025, and utilizes no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQU7ADelivery Order
The Defense Logistics Agency awarded a $56.9K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) with an ultimate completion date of February 9, 2026. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare systems globally. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in comprehensive medical product procurement for federal agencies. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military treatment facilities and other government healthcare systems. This delivery order represents a routine procurement of a specific pharmaceutical product executed under the company's established DLA framework contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.9k | 1/15/26 |